Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Viruses ; 10(6)2018 06 18.
Artigo em Inglês | MEDLINE | ID: mdl-29912170

RESUMO

The mouse mammary tumor virus (MMTV) Pr77Gag polypeptide is an essential retroviral structural protein without which infectious viral particles cannot be formed. This process requires specific recognition and packaging of dimerized genomic RNA (gRNA) by Gag during virus assembly. Most of the previous work on retroviral assembly has used either the nucleocapsid portion of Gag, or other truncated Gag derivatives­not the natural substrate for virus assembly. In order to understand the molecular mechanism of MMTV gRNA packaging process, we expressed and purified full-length recombinant Pr77Gag-His6-tag fusion protein from soluble fractions of bacterial cultures. We show that the purified Pr77Gag-His6-tag protein retained the ability to assemble virus-like particles (VLPs) in vitro with morphologically similar immature intracellular particles. The recombinant proteins (with and without His6-tag) could both be expressed in prokaryotic and eukaryotic cells and had the ability to form VLPs in vivo. Most importantly, the recombinant Pr77Gag-His6-tag fusion proteins capable of making VLPs in eukaryotic cells were competent for packaging sub-genomic MMTV RNAs. The successful expression and purification of a biologically active, full-length MMTV Pr77Gag should lay down the foundation towards performing RNA­protein interaction(s), especially for structure-function studies and towards understanding molecular intricacies during MMTV gRNA packaging and assembly processes.


Assuntos
Produtos do Gene gag/metabolismo , Vírus do Tumor Mamário do Camundongo/fisiologia , RNA Viral/metabolismo , Montagem de Vírus , Escherichia coli/genética , Expressão Gênica , Produtos do Gene gag/genética , Produtos do Gene gag/isolamento & purificação , Células HEK293 , Humanos , Vírus do Tumor Mamário do Camundongo/genética , Ligação Proteica , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Virossomos/metabolismo
2.
Biol Psychiatry ; 79(5): 402-414, 2016 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-26392130

RESUMO

BACKGROUND: Advanced Parkinson's disease (PD) is characterized by massive degeneration of nigral dopaminergic neurons, dramatic motor and cognitive alterations, and presence of nigral Lewy bodies, whose main constituent is α-synuclein (α-syn). However, the synaptic mechanisms underlying behavioral and motor effects induced by early selective overexpression of nigral α-syn are still a matter of debate. METHODS: We performed behavioral, molecular, and immunohistochemical analyses in two transgenic models of PD, mice transgenic for truncated human α-synuclein 1-120 and rats injected with the adeno-associated viral vector carrying wild-type human α-synuclein. We also investigated striatal synaptic plasticity by electrophysiological recordings from spiny projection neurons and cholinergic interneurons. RESULTS: We found that overexpression of truncated or wild-type human α-syn causes partial reduction of striatal dopamine levels and selectively blocks the induction of long-term potentiation in striatal cholinergic interneurons, producing early memory and motor alterations. These effects were dependent on α-syn modulation of the GluN2D-expressing N-methyl-D-aspartate receptors in cholinergic interneurons. Acute in vitro application of human α-syn oligomers mimicked the synaptic effects observed ex vivo in PD models. CONCLUSIONS: We suggest that striatal cholinergic dysfunction, induced by a direct interaction between α-syn and GluN2D-expressing N-methyl-D-aspartate receptors, represents a precocious biological marker of the disease.


Assuntos
Neurônios Colinérgicos/efeitos dos fármacos , Dopamina/fisiologia , Doença de Parkinson/tratamento farmacológico , Receptores de N-Metil-D-Aspartato/genética , alfa-Sinucleína/genética , Animais , Animais Geneticamente Modificados , Dependovirus , Modelos Animais de Doenças , Feminino , Humanos , Potenciação de Longa Duração , Masculino , Camundongos , Camundongos Transgênicos , Neostriado/fisiologia , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/genética , Transmissão Sináptica
3.
Acta Neuropathol ; 123(5): 653-69, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22361813

RESUMO

α-Synuclein (α-syn) is a presynaptic protein present at most nerve terminals, but its function remains largely unknown. The familial forms of Parkinson's disease associated with multiplications of the α-syn gene locus indicate that overabundance of this protein might have a detrimental effect on dopaminergic transmission. To investigate this hypothesis, we use adeno-associated viral (AAV) vectors to overexpress human α-syn in the rat substantia nigra. Moderate overexpression of either wild-type (WT) or A30P α-syn differs in the motor phenotypes induced, with only the WT form generating hemiparkinsonian impairments. Wild-type α-syn causes a reduction of dopamine release in the striatum that exceeds the loss of dopaminergic neurons, axonal fibers, and the reduction in total dopamine. At the ultrastructural level, the reduced dopamine release corresponds to a decreased density of dopaminergic vesicles and synaptic contacts in striatal terminals. Interestingly, the membrane-binding-deficient A30P mutant does neither notably reduce dopamine release nor it cause ultrastructural changes in dopaminergic axons, showing that α-syn's membrane-binding properties are critically involved in the presynaptic defects. To further determine if the affinity of the protein for membranes determines the extent of motor defects, we compare three forms of α-syn in conditions leading to pronounced degeneration. While membrane-binding α-syns (wild-type and A53T) induce severe motor impairments, an N-terminal deleted form with attenuated affinity for membranes is inefficient in inducing motor defects. Overall, these results demonstrate that α-syn overabundance is detrimental to dopamine neurotransmission at early stages of the degeneration of nigrostriatal dopaminergic axons.


Assuntos
Corpo Estriado/metabolismo , Dopamina/deficiência , Proteínas de Filamentos Intermediários/metabolismo , Atividade Motora/fisiologia , Substância Negra/metabolismo , Vesículas Sinápticas/metabolismo , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Anfetamina/farmacologia , Análise de Variância , Animais , Apomorfina/farmacologia , Cromatografia Líquida de Alta Pressão/métodos , Corpo Estriado/efeitos dos fármacos , Agonistas de Dopamina/farmacologia , Inibidores da Captação de Dopamina/farmacologia , Neurônios Dopaminérgicos/efeitos dos fármacos , Neurônios Dopaminérgicos/ultraestrutura , Eletroquímica , Ensaio de Imunoadsorção Enzimática/métodos , Comportamento Exploratório/efeitos dos fármacos , Comportamento Exploratório/fisiologia , Feminino , Lateralidade Funcional , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Vetores Genéticos/metabolismo , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Ácido Homovanílico/metabolismo , Humanos , Técnicas In Vitro , Proteínas de Filamentos Intermediários/genética , Proteínas de Filamentos Intermediários/ultraestrutura , Microscopia Eletrônica de Transmissão , Atividade Motora/efeitos dos fármacos , Mutação/genética , Potássio/farmacologia , Ratos , Ratos Sprague-Dawley , Substância Negra/efeitos dos fármacos , Substância Negra/ultraestrutura , Vesículas Sinápticas/ultraestrutura , Fatores de Tempo , Transdução Genética , Proteínas Vesiculares de Transporte de Monoamina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA